339 related articles for article (PubMed ID: 22500835)
41. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
[TBL] [Abstract][Full Text] [Related]
42. Control of lymphocyte differentiation by the LEF-1/TCF family of transcription factors.
Reya T; Okamura R; Grosschedl R
Cold Spring Harb Symp Quant Biol; 1999; 64():133-40. PubMed ID: 11232278
[No Abstract] [Full Text] [Related]
43. Stage-specific modulation of IFN-regulatory factor 4 function by Krüppel-type zinc finger proteins.
Gupta S; Anthony A; Pernis AB
J Immunol; 2001 May; 166(10):6104-11. PubMed ID: 11342629
[TBL] [Abstract][Full Text] [Related]
44. Requirement for cyclin D3 in germinal center formation and function.
Peled JU; Yu JJ; Venkatesh J; Bi E; Ding BB; Krupski-Downs M; Shaknovich R; Sicinski P; Diamond B; Scharff MD; Ye BH
Cell Res; 2010 Jun; 20(6):631-46. PubMed ID: 20404856
[TBL] [Abstract][Full Text] [Related]
45. Internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma.
Nakamura Y
Leuk Lymphoma; 2000 Aug; 38(5-6):505-12. PubMed ID: 10953971
[TBL] [Abstract][Full Text] [Related]
46. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
[TBL] [Abstract][Full Text] [Related]
47. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
48. An expanding job description for bcl6.
Bi E; Ye BH
J Mol Cell Biol; 2010 Feb; 2(1):5-7. PubMed ID: 19797315
[TBL] [Abstract][Full Text] [Related]
49. Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers.
Aggarwal A; Hunter WJ; Aggarwal H; Silva ED; Davey MS; Murphy RF; Agrawal DK
Exp Mol Pathol; 2010 Oct; 89(2):140-8. PubMed ID: 20471975
[TBL] [Abstract][Full Text] [Related]
50. BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells.
Ramachandrareddy H; Bouska A; Shen Y; Ji M; Rizzino A; Chan WC; McKeithan TW
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11930-5. PubMed ID: 20547840
[TBL] [Abstract][Full Text] [Related]
51. ZBTB Transcription Factors: Key Regulators of the Development, Differentiation and Effector Function of T Cells.
Cheng ZY; He TT; Gao XM; Zhao Y; Wang J
Front Immunol; 2021; 12():713294. PubMed ID: 34349770
[TBL] [Abstract][Full Text] [Related]
52. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
[TBL] [Abstract][Full Text] [Related]
53. BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma.
Saito M; Novak U; Piovan E; Basso K; Sumazin P; Schneider C; Crespo M; Shen Q; Bhagat G; Califano A; Chadburn A; Pasqualucci L; Dalla-Favera R
Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11294-9. PubMed ID: 19549844
[TBL] [Abstract][Full Text] [Related]
54. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
55. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707
[TBL] [Abstract][Full Text] [Related]
56. Deregulation of BCL6 in non-Hodgkin lymphoma by insertion of IGH sequences in complex translocations involving band 3q27.
Chaganti SR; Rao PH; Chen W; Dyomin V; Jhanwar SC; Parsa NZ; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):328-36. PubMed ID: 9824206
[TBL] [Abstract][Full Text] [Related]
57. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor.
Lemercier C; Brocard MP; Puvion-Dutilleul F; Kao HY; Albagli O; Khochbin S
J Biol Chem; 2002 Jun; 277(24):22045-52. PubMed ID: 11929873
[TBL] [Abstract][Full Text] [Related]
58. JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells.
Arguni E; Arima M; Tsuruoka N; Sakamoto A; Hatano M; Tokuhisa T
Int Immunol; 2006 Jul; 18(7):1079-89. PubMed ID: 16702165
[TBL] [Abstract][Full Text] [Related]
59. BCL6-Mediated Silencing of PD-1 Ligands in Germinal Center B Cells Maintains Follicular T Cell Population.
Peng C; Hu Q; Yang F; Zhang H; Li F; Huang C
J Immunol; 2019 Feb; 202(3):704-713. PubMed ID: 30567732
[TBL] [Abstract][Full Text] [Related]
60. Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator.
Stogios PJ; Chen L; Privé GG
Protein Sci; 2007 Feb; 16(2):336-42. PubMed ID: 17189472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
